Your search returned 3 results.

Results
	1.	Risk-stratified patients with resectable soft tissue sarcoma benefit from epirubicin-based adjuvant chemotherapy. [electronic resource] by Schenone, Aaron D Luo, Jingqin Montgomery, Luke Morgensztern, Daniel Adkins, Douglas R Van Tine, Brian A Producer: 20150212 In: Cancer medicine vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue. [electronic resource] by Fiorillo, Edoardo Orrú, Valeria Stanford, Stephanie M Liu, Yingge Salek, Mogjiborahman Rapini, Novella Schenone, Aaron D Saccucci, Patrizia Delogu, Lucia G Angelini, Federica Manca Bitti, Maria Luisa Schmedt, Christian Chan, Andrew C Acuto, Oreste Bottini, Nunzio Producer: 20100930 In: The Journal of biological chemistry vol. 285 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	A metabolic synthetic lethal strategy with arginine deprivation and chloroquine leads to cell death in ASS1-deficient sarcomas. [electronic resource] by Bean, Gregory R Kremer, Jeff C Prudner, Bethany C Schenone, Aaron D Yao, Juo-Chin Schultze, Matthew B Chen, David Y Tanas, Munir R Adkins, Douglas R Bomalaski, John Rubin, Brian P Michel, Loren S Van Tine, Brian A Producer: 20170731 In: Cell death & disease vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)